Pietro Fusaroli1, Adrian Saftoiu2, Christoph F Dietrich3. 1. Department of Medical and Surgical Science, Gastroenterology Unit, Hospital of Imola, University of Bologna, Bologna, Italy; Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, Craiova, Romania. 2. Research Center of Gastroenterology and Hepatology, University of Medicine and Pharmacy of Craiova, Craiova, Romania. 3. Department of Internal Medicine 2, Caritas-Krankenhaus Bad Mergentheim, Academic Teaching Hospital of the University of Würzburg, Würzburg, Germany.
Ultrasound contrast agents (UCAs) have become quintessential for differentiating liver and other abdominal lesions, alongside transabdominal B-mode imaging.[12]In recent years, the use of UCAs has become widespread also in endoscopic ultrasound (EUS) to enhance its diagnostic accuracy in pancreaticobiliary diseases.[345]Preliminary experience with the first-generation UCAs, dating back more than 15 years ago, used color and/or power Doppler imaging to perform contrast-enhanced EUS (CE-EUS). Subsequently, the second-generation UCAs were developed with dedicated contrast harmonic algorithms and quickly became established thanks to their safety and favorable learning curve.This special issue of EUS reports on the use of UCAs to investigate pancreatic lesions, gallbladder abnormalities, submucosal tumors, lymph nodes, and other pathological conditions.Different acronyms have been used over the years to refer to techniques incorporating UCAs. To improve comprehension of the articles in this special issue, it is worthwhile clarifying the meaning of all these terms.Contrast-enhanced ultrasound (CEUS) was introduced as an acronym by members of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) and finally accepted as the official term describing CEUS techniques in general.[1267]Similarly, the acronym CE-EUS is used as a generic term for all contrast-enhanced techniques used with EUS, independent of particular physical principles.Contrast enhancement techniques during EUS examinations are possible using low or high mechanical index (MI). Therefore, the acronyms for contrast-enhanced low MI-EUS (CELMI-EUS, first applied in 2003 and published in 2005 and 2009)[89] and contrast-enhanced high MI-EUS (CEHMI-EUS, first published in 1997 and 2001) ensued.[10111213]Analogous to the original percutaneous approaches, CELMI-EUS describes low MI techniques, including filter/wide-band harmonic (phase or pulse) or cancellation techniques. Consequently, the terms contrast-enhanced harmonic-EUS (CEH-EUS) and contrast harmonic EUS (CH-EUS) have been used to describe low MI techniques.[14151617181920]Contrast-enhanced endoscopic Doppler techniques (color Doppler, power Doppler, others) use high MI and, therefore, are included under the acronyms CEHMI-EUS or CED-EUS (contrast-enhanced Doppler-EUS). However, higher MI techniques are also used for (intermittent) harmonic imaging.Dynamic CEUS has been adopted as the term describing time-intensity curve analysis.[521] Furthermore, CEUS three-dimensional (3D) techniques were introduced as early as 2002,[22] followed by CE-EUS 3D.[2324] All the acronyms described to date are independent of the additional terminology used by manufacturers.The current manufacturer's terms for low MI examination modes are as follows:Wideband Pulse Inversion Contrast Harmonic Imaging (Hitachi-Pentax)Contrast Harmonic-enhanced Imaging based on Extended Pure Harmonic Detection (Olympus-Aloka)Contrast-harmonic Imaging-EUS (Fujinon).Nevertheless, CEH-EUS and CH-EUS are the most widely utilized acronyms by the majority of authors. Further efforts to standardize terminology and acronyms are underway by several authorities under the auspices of the EFSUMB.
Authors: M Claudon; D Cosgrove; T Albrecht; L Bolondi; M Bosio; F Calliada; J-M Correas; K Darge; C Dietrich; M D'Onofrio; D H Evans; C Filice; L Greiner; K Jäger; N de Jong; E Leen; R Lencioni; D Lindsell; A Martegani; S Meairs; C Nolsøe; F Piscaglia; P Ricci; G Seidel; B Skjoldbye; L Solbiati; L Thorelius; F Tranquart; H P Weskott; T Whittingham Journal: Ultraschall Med Date: 2008-02 Impact factor: 6.548
Authors: F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott Journal: Ultraschall Med Date: 2011-08-26 Impact factor: 6.548
Authors: B Napoleon; M V Alvarez-Sanchez; R Gincoul; B Pujol; C Lefort; V Lepilliez; M Labadie; J C Souquet; P E Queneau; J Y Scoazec; J A Chayvialle; T Ponchon Journal: Endoscopy Date: 2010-06-30 Impact factor: 10.093
Authors: Christoph F Dietrich; Michalakis Averkiou; Michael Bachmann Nielsen; Richard G Barr; Peter N Burns; Fabrizio Calliada; Vito Cantisani; Byung Choi; Maria C Chammas; Dirk-André Clevert; Michel Claudon; Jean-Michel Correas; Xin-Wu Cui; David Cosgrove; Mirko D'Onofrio; Yi Dong; JohnR Eisenbrey; Teresa Fontanilla; Odd Helge Gilja; Andre Ignee; Christian Jenssen; Yuko Kono; Masatoshi Kudo; Nathalie Lassau; Andrej Lyshchik; Maria Franca Meloni; Fuminori Moriyasu; Christian Nolsøe; Fabio Piscaglia; Maija Radzina; Adrian Saftoiu; Paul S Sidhu; Ioan Sporea; Dagmar Schreiber-Dietrich; Claude B Sirlin; Maria Stanczak; Hans-Peter Weskott; Stephanie R Wilson; Juergen Karl Willmann; Tae Kyoung Kim; Hyun-Jung Jang; Alexandar Vezeridis; Sue Westerway Journal: Ultrasound Int Open Date: 2018-02-07
Authors: Victor Mihai Sacerdoțianu; Bogdan Silviu Ungureanu; Sevastiţa Iordache; Sergiu Marian Cazacu; Daniel Pirici; Ilona Mihaela Liliac; Daniela Elena Burtea; Valeriu Șurlin; Cezar Stroescu; Dan Ionuț Gheonea; Adrian Săftoiu Journal: J Pers Med Date: 2022-06-21
Authors: Christoph F Dietrich; Yi Dong; Christian Jenssen; Valentina Ciaravino; Michael Hocke; Wen-Ping Wang; Eike Burmester; Kathleen Moeller; Nathan Ss Atkinson; Paola Capelli; Mirko D'Onofrio Journal: World J Gastroenterol Date: 2017-08-14 Impact factor: 5.742